.png)
NextGen Biomed 2027
.svg)
InterContinental London - The O2, UK
PART OF NEXTGEN BIOMED 2027
18 - 19 March 2027 | InterContinental London - The O2, London, UK
Delve into the latest advances in cross-modality translational development, bringing together approaches spanning proteins, antibodies, ADCs, peptides, oligonucleotides and immunotherapies. Explore predictive disease models, PK/PD, NAMs, multi-omics and biomarker strategies designed to improve translational confidence, strengthen candidate selection and accelerate the path from preclinical development to first-in-human studies.
AI for Smarter Patient Selection: Explore how AI/ML is being applied to predict response, toxicity and efficacy, enabling more informed patient selection and early clinical development.
Biomarkers to Strengthen Translation: Discover strategies for identifying and validating translational biomarkers to demonstrate target engagement, guide patient selection and improve confidence from preclinical development through first-in-human studies.
leading pharma, biotech, regulatory & academic delegates
Unlock the Latest News and Insights
Sign-up for our regular LifeScienceXchange newsletter to keep up to date with all things NextGen Biomed, direct to your inbox.
Agenda at a Glance
DAY ONE TRACK
Track 8: Translational Development: Disease Modeling, PK/PD A7 NAMs
DAY TWO TRACK
Track 7: Multi-Omics & Biomarker Strategies: Early Clinical Development
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Partner with us
Become a driving force in accelerating the next generation of advances in translational development